MTOR and acute lymphoblastic leukemia: The effects of AICAR were enhanced by combination with the mTOR inhibitor rapamycin in all different ALL cell lines tested in that study [56], while the growth inhibitory responses were mediated in part by engagement of the p38 MAP kinase pathway.